Skip to main content
Fuan Pharmaceutical （Group）co.,Ltd logo

Fuan Pharmaceutical （Group）co.,Ltd — Investor Relations & Filings

Ticker · 300194 ISIN · CNE1000011G4 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,014 across all filing types
Latest filing 2018-03-30 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 300194

About Fuan Pharmaceutical （Group）co.,Ltd

https://www.fapharm.com

Fuan Pharmaceutical (Group) Co., Ltd. is an integrated pharmaceutical enterprise specializing in the research, development, production, and distribution of a wide range of chemical drugs. The company operates across the entire value chain, encompassing pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and finished dosage forms. Its product portfolio primarily focuses on anti-infectives, particularly cephalosporins and penicillins, as well as treatments for cardiovascular diseases, oncology, and respiratory conditions. Fuan Pharmaceutical maintains large-scale manufacturing facilities and emphasizes technological innovation to support its diverse pipeline of generic and specialized medications. The group serves both domestic and international markets, providing essential healthcare solutions through its network of subsidiaries and specialized production bases.

Recent filings

Filing Released Lang Actions
关于使用闲置自有资金购买低风险理财产品的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by 福安药业（集团）股份有限公司 regarding the use of idle self-owned funds to purchase low-risk financial products. It details the investment plan, risk control measures, board and supervisory approvals, and confirms that the investment does not affect normal operations or constitute a major asset restructuring. The document is an announcement of a financing or capital management activity rather than a financial report or earnings release. It does not contain financial statements or detailed financial results. The content fits best under Capital/Financing Update (CAP) as it relates to the company's capital management and investment of idle funds in financial products.
2018-03-30 Chinese
2017年度业绩快报
Earnings Release Classification · 95% confidence The document is titled '年度业绩快报' which translates to 'Annual Performance Express Report' or 'Annual Earnings Quick Report' for the year 2017. It contains preliminary financial data such as total revenue, profit, net profit attributable to shareholders, earnings per share, and asset information. The document explicitly states that the data is preliminary, unaudited, and that the final audited data will be disclosed in the full annual report. This indicates it is a financial results announcement rather than a full annual report. The document length is 2037 characters, which is relatively short and consistent with a brief earnings release or performance summary. It is not a full 10-K or Annual Report (which would be much longer and audited). It is not a call transcript, management report, or other categories. Therefore, the best fit is Earnings Release (ER), which is the initial announcement of yearly financial results with key highlights only. FY 2017
2018-02-27 Chinese
关于收到药品注册批件的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from a company regarding the receipt of drug registration approvals from the national food and drug regulatory authority. It contains no financial data, no discussion of financial results, no management commentary on financial performance, and no mention of shareholder votes or meetings. The document is short (848 characters) and serves as a regulatory update about product approvals. It does not fit into categories like Annual Report, Earnings Release, or Management Reports. It is not a report publication announcement since it is the announcement itself. The best fitting category is Regulatory Filings (RNS), which covers general regulatory announcements and compliance-related disclosures that do not fit other specific categories.
2018-02-26 Chinese
关于部分高管股份减持计划实施进展情况的公告
Director's Dealing Classification · 100% confidence The document is an announcement regarding the progress of a share reduction plan by certain senior executives of the company. It details the status of share sales by specific executives, references regulatory compliance with securities laws and stock exchange rules, and confirms that the share reduction does not affect control of the company. The document is not a financial report, earnings release, or management discussion, but rather a regulatory disclosure about insider share transactions. This fits the definition of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades). The document length is short and focused solely on this topic, confirming the classification.
2018-02-26 Chinese
关于股东股份减持计划期间届满暨实施情况的公告
Major Shareholding Notification Classification · 100% confidence The document is an announcement regarding the completion and details of a shareholder's share reduction plan. It includes specific information about the shareholder's shareholding before and after the reduction, the method and timing of the share sales, and compliance with relevant securities laws and regulations. There is no financial statement or report content, but rather a disclosure of shareholding changes by a significant shareholder. This fits the category of Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels.
2018-02-22 Chinese
关于控股股东部分股份质押的公告
Major Shareholding Notification Classification · 95% confidence The document is a short announcement regarding the pledge of shares by a controlling shareholder. It includes details about the number of shares pledged, the shareholder's name, and the pledge date. There is no financial data, no mention of a report being attached or published, and no indication of a full financial report or regulatory certification. The content fits the description of a notification about share pledging, which is related to changes in share ownership or capital structure but specifically about share pledges by a major shareholder. This aligns best with the category 'Major Shareholding Notification (MRQ)' as it reports on significant share ownership changes due to pledging.
2018-02-14 Chinese

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.